Why Is PaO(2) Not Enough? Arterial Oxygen Content as a Prognostic Indicator in COPD Patients

为什么动脉血氧分压(PaO2)不足以作为慢性阻塞性肺疾病(COPD)患者的预后指标?

阅读:1

Abstract

BACKGROUND: Chronic hypoxemia in patients with COPD is associated with increased morbidity and mortality. Although arterial partial pressure of oxygen (PaO(2)) is widely used, it does not adequately reflect systemic oxygen transport. Arterial oxygen content (CaO(2)) may provide a more comprehensive assessment. OBJECTIVE: This study aimed to evaluate whether or not CaO(2) is a better predictor of mortality than PaO(2) in patients with COPD. METHODS: This retrospective observational cohort study included 147 COPD patients aged ≥45 years. Patients were categorized according to CaO(2) levels (low, normal, high). Mortality at 1, 3, and 5 years was analyzed. Statistical methods included ROC curves, Kaplan-Meier survival analysis, and Cox regression models. RESULTS: A total of 66 deaths (45.2%) occurred in the study cohort. Mortality was highest in the low CaO(2) group. The CaO(2) demonstrated better predictive performance than PaO(2) (AUC 0.73 versus 0.53, respectively). Low CaO(2) was associated with a 2.5-fold increased risk of mortality. Despite improvements in PaO(2) after long-term oxygen therapy, CaO(2) did not significantly change. CONCLUSIONS: The CaO(2) is a more informative marker of oxygen transport and mortality risk than PaO(2) in COPD patients. It should be considered a complementary parameter in clinical assessment.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。